Cargando…
Controversies in colorectal cancer: First line treatment with epidermal growth factor inhibitors and RAS in 2014
Autor principal: | Junior, Gilberto de Lima Lopes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4152630/ https://www.ncbi.nlm.nih.gov/pubmed/25197175 http://dx.doi.org/10.4103/0971-5851.138960 |
Ejemplares similares
-
Adjuvant therapy for resected high-risk colon cancer: Current standards and controversies
por: Gill, Sharlene
Publicado: (2014) -
Controversies in the Treatment of Follicular Lymphoma
por: Hübel, Kai, et al.
Publicado: (2020) -
Controversies in the Treatment of Classical Hodgkin Lymphoma
por: Eichenauer, Dennis A., et al.
Publicado: (2018) -
Controversies in the Treatment of Peripheral T-cell Lymphoma
por: Bachy, Emmanuel, et al.
Publicado: (2020) -
Controversies on the Consequences of Iron Overload and Chelation in MDS
por: Vinchi, Francesca, et al.
Publicado: (2020)